Cancer Treatment
Ten years left to live: Cancer-free, but life is not the same as it was - opinion
I won’t stop writing, dear readers, but maybe I’ll put more time into personal projects, including several new book ideas that should keep me alert and engaged.
Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim
The complementary treatment that cancer patients asked to continue even after it ended
Daniel turned a family tragedy into a lifesaving search engine
Make-A-Wish Israel Changing ‘impossible’ to ‘possible’
‘The words ‘Making the impossible possible’ are inscribed on my desk. That’s what Make-A-Wish is all about,” says Denise Bar-Aharon, co-founder and CEO of Make-A-Wish Israel.
Children and teens with cancer fight an additional battle - opinion
Amid the sea of collective pain that we navigate as a nation, life is a gift worth cherishing every single day.
Tel Aviv University researchers develop new cancer-fighting system - study
The researchers developed nanoparticles, which dissolve into water and carbon dioxide within a month, to encapsulate two different cancer- fighting drugs.
‘I’ve never been with a bald man before’ - opinion
“I’ve always found the Israeli-man-with-the-shaved-head look to be very sexy,” my wife, Jody, said.
Colorectal cancer numbers trending down in Israel
Israel has seen a significant annual decrease of 2-3% in the incidence of colorectal cancer among women and men.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Exciting testimonies about the innovative cancer treatment
Discover the revolution in CLL treatment: Dr. Evelyn Shabad and Carol Gilad share insights on follow-up, short-term treatment, and surprising results without major side effects.
Israeli study uncovers cancer cell findings that may advance treatment for the disease
Researchers at Tel Aviv University found that aneuploid cancer cells are more sensitive to certain anti-cancer drugs, revealing potential targets for new treatments.
Leading Cancer institute Dana-Farber to partner with OncoHost for groundbreaking cancer study
Pioneering Kidney Cancer Study Seeks to Improve Treatment Outcomes through Precision Medicine
Gamida Cell has a second chance to be an Israeli success story
TECH TALK | No one loves needing to ask for a helping hand, but when potentially life-saving technology is at stake, some extra measures must be taken.
